Press Releases 

Helomics® Corporation Announces the Launch of D-CHIP™, a Clinical Knowledge Bioinformatics Platform

PITTSBURGH– April 12, 2017 - Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, today announced the launch of D-CHIP™ (Dynamic Clinical Health Insight Platform), a bioinformatics platform for use by pharmaceutical and diagnostic companies to power their precision medicine efforts. D-CHIP™ is a searchable, bioinformatics platform that can be used by researchers to mine proprietary data of rich multi-omic and clinical information on patients with cancer to drive biomarker discovery and development, virtual clinical trials, as well as patient recruitment and selec

Helomics® Corporation Announces the Organization of a New Advisory Board of Biotechnology Experts

PITTSBURGH– April 11, 2017 - Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, today announced the formation of an Advisory Board with over 100 years of combined experience in pharmaceutical, diagnostic, biotechnological, and clinical research industries. The first renowned professionals to accept seats on Helomics’ Advisory Board include Dr. Amelia Warner of Global Specimen Solutions and Dr. Paul Kornblith, Founder and former Chairman and CEO of Precision Therapeutics (later renamed Helomics) and the current Medical Advisor at Helomics. Amelia Wall Warner, Ph

Archive
 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon